jp morgan positive news but still neutral, page-2

Also from FNARENA - 7th April 09

UBS rates BJT as Buy - While internalising management resolves one issue the broker takes the view for any re-rating to occur the company must demonstrate a better standing with its counter-parties.
On the plus side liquidity is improving for the company and while a review of its numbers post the restructuring is not yet completed the broker retains its Buy rating.


Target price is $0.50 Current Price is $0.27 Difference:$0.24 - (brackets indicate current price is over target). If BJT meets the UBS target it will return approximately 89% (excluding dividends, fees and charges - negative figures indicate an expected loss).

The company's fiscal year ends in June. UBS forecasts a full year FY09 dividend of 8.00 cents and EPS of 13.20 cents. At the last closing share price the estimated dividend yield is 30.19%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 2.01.